Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease
Sponsor: Gordon Schanzlin New Vision
Summary
The primary objective of this study is to show that consistent use of Systane PRO over a 30 period will significantly improve the signs and symptoms of Dry Eye Disease and decrease patients' ocular surface disease index score for patients diagnosed with mild-moderate (DED).
Official title: The Effectiveness of Systane PRO in Providing Relief From Multiple Symptoms of Dry Eye Disease and Its Impact on Daily Functioning and Overall Comfort in Patients With Mild to Moderate Dry Eye Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
33
Start Date
2025-11-01
Completion Date
2026-02-01
Last Updated
2026-06-17
Healthy Volunteers
No
Conditions
Interventions
Systane Pro Topical Ophthalmic
To show that consistent use of Systane PRO will significantly improve the signs and symptoms of Dry Eye Disease in patients with mild-moderate DED.
Locations (1)
Gordon Schanzlin New Vision Institute
La Jolla, California, United States